Human coinfection with Borrelia burgdorferi and Babesia microti in the United States

Journal of Parasitology Research

Volumn 2015, Issue , 2015, Pages

  Knapp, Kristen L ^a   Rice, Nancy A ^a  

^a WESTERN KENTUCKY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABESIA MICROTI; BABESIA MICROTI INFECTION; BORRELIA BURGDORFERI; CLINICAL FEATURE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYME DISEASE; MIXED INFECTION; NONHUMAN; PATHOPHYSIOLOGY; PIROPLASMOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED STATES;

EID: 84949956334     PISSN: 20900023     EISSN: 20900031     Source Type: Journal    
DOI: 10.1155/2015/587131     Document Type: Review

References (69)

1. J. H. Oliver Jr., M. R. Owsley, H. J. Hutcheson et al., "Con-specifcity of the ticks Ixodes scapularis and I. dammini (Acari: Ixodidae)," Journal of Medical Entomology, vol. 30, no. 1, pp. 54-63, 1993.
2. Center for Disease Control and Prevention, Ticks-Geographic Distribution of Ticks Tat Bite Humans, 2015, http://www.cdc.gov/ticks/geographic distribution.html.
3. Center for Disease Control and Prevention, Lyme Disease, 2015, http://www.cdc.gov/lyme/index.html.
4. E. R. Adrion, J. Aucott, K. W. Lemke, and J. P. Weiner, "Health care costs, utilization and patterns of care following Lyme disease," PLoS ONE, vol. 10, no. 2, Article ID 0116767, 2015.
5. J. Bogitsh, E. Carter, and T. Oeltmann, Human Parasitology, Academic Press, Oxford, UK, 4th edition, 2005.
6. Center for Disease Control and Prevention, Parasites-Babesi-osis, 2015, http://www.cdc.gov/parasites/babesiosis/data-statis-tics/index.html#Babesiosis.
7. Center for Disease Control and Prevention, "Map-Reported Cases of Lyme Disease," 2015, http://www.cdc.gov/lyme/stats/ maps/map2013.html.
8. P. D. Mitchell, K. D. Reed, and J. M. Hofes, "Immunosero-logic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota," Journal of Clinical Microbiology, vol. 34, no. 3, pp. 724-727, 1996.
9. M. E. Adelson, R.-V. S. Rao, R. C. Tilton et al., "Prevalence of Borrelia burgdorferi, Bartonella spp., Babesia microti, and Anaplasma phagocytophila in Ixodes scapularis ticks collected in Northern New Jersey," Journal of Clinical Microbiology, vol. 42, no. 6, pp. 2799-2801, 2004.
10. K. I. Swanson and D. E. Norris, "Co-circulating microorganisms in questing Ixodes scapularis nymphs in Maryland," Journal of Vector Ecology, vol. 32, no. 2, pp. 243-251, 2007.
11. J. F. Anderson, R. C. Johnson, L. A. Magnarelli, F. W. Hyde, and J. E. Myers, "Peromyscus leucopus and Microtus pennsylvanicus simultaneously infected with Borrelia burgdorferi and Babesia microti," Journal of Clinical Microbiology, vol. 23, no. 1, pp. 135-137, 1986.
12. S. Varde, J. Beckley, and I. Schwartz, "Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County," Emerging Infectious Diseases, vol. 4, no. 1, pp. 97-99, 1998.
13. J. Piesman, T. C. Hicks, R. J. Sinsky, and G. Obiri, "Simultaneous transmission of Borrelia burgdorferi and Babesia microti by individual nymphal Ixodes dammini ticks," Journal of Clinical Microbiology, vol. 25, no. 10, pp. 2012-2013, 1987.
14. L. A. Magnarelli, K. C. Staford III, J. W. Ijdo, and E. Fikrig, "Antibodies to whole-cell or recombinant antigens of Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti in white-footed mice," Journal of Wildlife Diseases, vol. 42, no. 4, pp. 732-738, 2006.
15. L. A. Magnarelli, S. C. Williams, S. J. Norris, and E. Fikrig, "Serum antibodies to Borrelia burgdorferi, Anaplasma phagocy-tophilum, and Babesia microti in recaptured white-footed mice," Journal of Wildlife Diseases, vol. 49, no. 2, pp. 294-302, 2013.
16. L. A. Magnarelli, J. F. Anderson, K. C. Staford III, and J. S. Dumler, "Antibodies to multiple tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in white-footed mice," Journal of Wildlife Diseases, vol. 33, no. 3, pp. 466-473, 1997.
17. C. C. Dos Santos and K. C. Kain, "Two tick-borne diseases in one: a case report of concurrent babesiosis and Lyme disease in Ontario," Canadian Medical Association Journal, vol. 160, no. 13, pp. 1851-1853, 1999.
18. P. J. Krause, S. R. Telford, A. Spielman et al., "Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness," Journal of the American Medical Association, vol. 275, no. 21, pp. 1657-1660, 1996.
19. J. L. Benach, J. L. Coleman, G. S. Habicht, A. MacDonald, E. Grunwaldt, and J. A. Giron, "Serological evidence for simultaneous occurrences of Lyme disease and babesiosis," Journal of Infectious Diseases, vol. 152, no. 3, pp. 473-477, 1985.
20. C. Tompson, A. Spielman, and P. J. Krause, "Coinfecting deer-associated zoonoses: lyme disease, babesiosis, and ehrlichiosis," Clinical Infectious Diseases, vol. 33, no. 5, pp. 676-685, 2001.
21. L. C. Marcus, A. C. Steere, P. H. Duray, A. E. Anderson, and E. B. Mahoney, "Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium," Annals of Internal Medicine, vol. 103, no. 3, pp. 374-376, 1985.
22. T. J. Wang, M. H. Liang, O. Sangha et al., "Coexposure to Bor-relia burgdorferi and Babesia microti does not worsen the longterm outcome of Lyme disease," Clinical Infectious Diseases, vol. 31, no. 5, pp. 1149-1154, 2000.
23. N. W. J. Schröder, J. Eckert, G. Stübs, and R. R. Schumann, "Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids," Immunobiology, vol. 213, no. 3-4, pp. 329-340, 2008.
24. M. Hirschfeld, G. J. Kirschning, R. Schwandner et al., "Cutting edge: infammatory signaling by Borrelia burgdorferi lipopro-teins is mediated by toll-like receptor 2," Journal of Immunology, vol. 163, no. 5, pp. 2382-2386, 1999.
25. M. Guerau-de-Arellano and B. T. Huber, "Chemokines and Toll-like receptors in Lyme disease pathogenesis," Tre nd s in Molecular Medicine, vol. 11, no. 3, pp. 114-120, 2005.
26. B. H. Skogman, S. Hellberg, C. Ekerfelt et al., "Adaptive and innate immune responsiveness to Borrelia burgdorferi sensu lato in exposed asymptomatic children and children with previous clinical Lyme borreliosis," Clinical and Developmental Immunology, vol. 2012, Article ID 294587, 10 pages, 2012.
27. J. Oksi, J. Savolainen, J. Pène, J. Bòusquet, P. Laippala, and M. K. Viljanen, "Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis," Infection and Immunity, vol. 64, no. 9, pp. 3620-3623, 1996.
28. C. Ekerfelt, J. Ernerudh, J. Bunikis et al., "Compartmental-ization of antigen specifc cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes," Journal of Neu-roimmunology, vol. 79, no. 2, pp. 155-162, 1997.
29. M. Widhe, S. Jarefors, C. Ekerfelt et al., "Borrelia-specifc interferon-β and interleukin-4 secretion in cerebrospinal fuid and blood during lyme borreliosis in humans: association with clinical outcome," Journal of Infectious Diseases, vol. 189, no. 10, pp. 1881-1891, 2004.
30. M. Widhe, B. H. Skogman, S. Jarefors et al., "Up-regulation of Borrelia-specifc IL-4-and IFN-β-secreting cells in cere-brospinal fuid from children with Lyme neuroborreliosis," International Immunology, vol. 17, no. 10, pp. 1283-1291, 2005.
31. J. E. Matyniak and S. L. Reiner, "T helper phenotype and genetic susceptibility in experimental Lyme disease," Journal of Experimental Medicine, vol. 181, no. 3, pp. 1251-1254, 1995.
32. A. K. Abbas, A. H. Lichtman, and S. Pillai, Cellular and Molecular Immunology, Elsevier, Philadelphia, Pa, USA, 8th edition, 2015.
33. P. Kraiczy, J. Hellwage, C. Skerka et al., "Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins," The Journal of Biological Chemistry, vol. 279, no. 4, pp. 2421-2429, 2004.
34. K. Hartmann, C. Corvey, C. Skerka et al., "Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1," Molecular Microbiology, vol. 61, no. 5, pp. 1220-1236, 2006.
35. P. Kraiczy, C. Skerka, M. Kirschfnk, V. Brade, and P. F. Zipfel, "Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H," European Journal of Immunology, vol. 31, no. 6, pp. 1674-1684, 2001.
36. P. Kraiczy and B. Stevenson, "Complement regulator-acquiring surface proteins of Borrelia burgdorferi: structure, function and regulation of gene expression," Ticks and Tick B or ne Diseas es, vol. 4, no. 1-2, pp. 26-34, 2013.
37. J. Hellwage, T. Meri, T. Heikkilä et al., "The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi," The Journal of Biological Chemistry, vol. 276, no. 11, pp. 8427-8435, 2001.
38. A. Bhattacharjee, J. S. Oeemig, R. Kolodziejczyk et al., "Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi," The Journal of Biological Chemistry, vol. 288, no. 26, pp. 18685-18695, 2013.
39. A. Kern, E. Collin, C. Barthel, C. Michel, B. Jaulhac, and N. Boulanger, "Tick saliva represses innate immunity and cutaneous infammation in a murine model of Lyme disease," Vector-Borne and Zoonotic Diseases, vol. 11, no. 10, pp. 1343-1350, 2011.
40. M. D. McKisic and S. W. Barthold, "T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease," Infection and Immunity, vol. 68, no. 9, pp. 5190-5197, 2000.
41. C. A. Lobo, J. R. Cursino-Santos, A. Alhassan, and M. Rod-rigues, "Babesia: an emerging infectious threat in transfusion medicine," PLoS Pathogens, vol. 9, no. 7, Article ID e1003387, 2013.
42. S. Kumar, D. M. Gubernot, H. L. Nakhasi, P. A. Mied, D. M. Asher, and J. S. Epstein, "Transfusion-transmitted babesiosis in the United States: summary of a workshop," Transfusion, vol. 49, no. 12, pp. 2759-2771, 2009.
43. D. A. Leiby, "Transfusion-associated babesiosis: shouldn't we be ticked of?" Annals of Internal Medicine, vol. 155, no. 8, pp. 556-557, 2011.
44. M. J. Homer, I. Aguilar-Delfn, S. R. Telford III, P. J. Krause, and D. H. Persing, "Babesiosis," Clinical Microbiology Reviews, vol. 13, no. 3, pp. 451-469, 2000.
45. I. Aguilar-Delfn, P. J. Wettstein, and D. H. Persing, "Resistance to acute babesiosis is associated with interleukin-12-and gamma interferon-mediated responses and requires macrophages and natural killer cells," Infection and Immunity, vol. 71, no. 4, pp. 2002-2008, 2003.
46. + T cells and gamma interferon in protective immunity against Babesia microti infection in mice," Infection and Immunity, vol. 67, no. 8, pp. 4143-4148, 1999.
47. M. Takahashi, Y. Omata, H. Oikawa et al., "Protective immune response of Isospora felis-infected mice against Babesia microti infection," The Journal of Veterinary Medical Science, vol. 55, no. 4, pp. 587-590, 1993.
48. Y. Li, M. A. Terkawi, Y. Nishikawa et al., "Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice," Infection and Immunity, vol. 80, no. 1, pp. 311-320, 2012.
49. D. Chen, D. B. Copeman, J. Burnell, and G. W. Hutchinson, "Helper T cell and antibody responses to infection of CBA mice with Babesia microti," Parasite Immunology, vol. 22, no. 2, pp. 81-88, 2000.
50. M. Perez, C. A. Carson, and M. Ristic, "Cell-mediated immune response in hamsters infected with Babesia microti," Veterinary Parasitology, vol. 3, no. 2, pp. 161-167, 1977.
51. J. Vinasco, W. Braga, O. Zegarra-Moro, and M. H. Moro, "Cellular immune responses in a Murine model of Borrelia burgdorferi and Babesia microti coinfection," The Journal of Immunology, vol. 178, article S47, 2007.
52. C. Martinez-Balzano, M. Hess, A. Malhotra, and R. Lenox, "Severe babesiosis and Borrelia burgdorferi coinfection," QJM, vol. 108, no. 2, pp. 141-143, 2015.
53. Y. M. Abrams, "Complications of coinfection with Babesia and Lyme disease afer splenectomy," Journal of the American Board of Family Medicine, vol. 21, no. 1, pp. 75-77, 2008.
54. M. H. Moro, O. L. Zegarra-Moro, J. Bjornsson et al., "Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microti," Journal of Infectious Diseases, vol. 186, no. 3, pp. 428-431, 2002.
55. J. L. Coleman, D. LeVine, C. Till, C. Kuhlow, and J. L. Benach, "Babesia microti and Borrelia burgdorferi follow independent courses of infection in mice," Journal of Infectious Diseases, vol. 192, no. 9, pp. 1634-1641, 2005.
56. S. T. Qureshi, L. Larivière, G. Leveque et al., "Endotoxin-toler-ant mice have mutations in toll-like receptor 4 (Tlr4)," Journal of Experimental Medicine, vol. 189, no. 4, pp. 615-625, 1999.
57. W. Leitner, T. Wali, and A. C.-S. Denis, "Is arthropod saliva the Achilles' heel of vector-borne diseases?" Frontiers in Immunology, vol. 4, article 255, 2013.
58. G. Chen, M. S. Severo, M. Sohail et al., "Ixodes scapularis saliva mitigates infammatory cytokine secretion during Anaplasma phagocytophilum stimulation of immune cells," Parasites & Vectors, vol. 5, article 229, 2012.
59. J. Dai, P. Wang, S. Adusumilli et al., "Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent," Cell Host and Microbe, vol. 6, no. 5, pp. 482-492, 2009.
60. N. Ramamoorthi, S. Narasimhan, U. Pal et al., "The Lyme disease agent exploits a tick protein to infect the mammalian host," Nature, vol. 436, no. 7050, pp. 573-577, 2005.
61. T. J. Schuijt, J. Coumou, S. Narasimhan et al., "A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the Lyme disease agent," Cell Host and Microbe, vol. 10, no. 2, pp. 136-146, 2011.
62. R. B. Stricker, J. J. Burrascano, N. S. Harris et al., "Coinfection with Borrelia burgdorferi and Babesia microti: bad or worse?" Journal of Infectious Diseases, vol. 193, no. 6, pp. 901-902, 2006.
63. Center for Disease Control and Prevention, Statistics-Ana-plasmosis, Center for Disease Control and Prevention, 2013, http://www.cdc.gov/anaplasmosis/stats/#casesbyyear.
64. K. Holden, E. Hodzic, S. Feng, K. J. Freet, R. B. Lefebvre, and S. W. Barthold, "Coinfection with Anaplasma phagocytophilum alters Borrelia burgdorferi population distribution in C3H/HeN mice," Infection and Immunity, vol. 73, no. 6, pp. 3440-3444, 2005.
65. D. J. Grab, E. Nyarko, N. C. Barat, O. V. Nikolskaia, and J. S. Dumler, "Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine, and matrix metallo-protease expression by human brain microvascular endothelial cells," Clinical and Vaccine Immunology, vol. 14, no. 11, pp. 1420-1424, 2007.
66. H. W. Horowitz, M. E. Aguero-Rosenfeld, D. Holmgren et al., "Lyme disease and human granulocytic anaplasmosis coinfec-tion: impact of case defnition on coinfection rates and illness severity," Clinical Infectious Diseases, vol. 56, no. 1, pp. 93-99, 2013.
67. J. L. Gugliotta, H. K. Goethert, V. P. Berardi, and S. R. Telford III, "Meningoencephalitis from Borrelia miyamotoi in an immuno-compromised patient," The New England Journal of Medicine, vol. 368, no. 3, pp. 240-245, 2013.
68. P. J. Krause, S. Narasimhan, G. P. Wormser et al., "Human Borrelia miyamotoi infection in the United States," The New England Journal of Medicine, vol. 368, no. 3, pp. 291-293, 2013.
69. Powassan Virus (POW) Basics, Minnesota Department of Health, http://www.health.state.mn.us/divs/idepc/diseases/po-wassan/basics.html.